TOP TIERMARKET NEWSWIRE

News & sentiment

VAXART INC (VXRT) — News & AI sentiment

VAXART INC (VXRT) news roundup. 2 stories in the past week, 9 over 30 days. Average 30-day sentiment is 55.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

2

avg sentiment 56/100

30d stories

9

avg sentiment 55.9/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

VXRT news in the last 24 hours, 7 days, 30 days and 90 days

How much VXRT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	VXRT stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	2	56/100	VXRT headlines →
Last 30 days	9	55.9/100	VXRT headlines →
Last 90 days	40	54.8/100	VXRT headlines →

Latest stories on VXRT

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire56 · neutralgeneral

5d ago

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Business Insider56 · neutralgeneral

5d ago

V2X General Counsel Sells 3,500 Shares

Yahoo Top48 · neutralgeneral

Sep 2

V2X General Counsel Sells 3,500 Shares

The Motley Fool48 · neutralgeneral

Sep 2

Vaxart, Inc. (VXRT) Q2 2026 Stockholder Fireside Chat Call Transcript

Seeking Alpha63 · neutralproduct/pr

Aug 31

Vaxart granted European patent covering oral norovirus vaccine through 2036

The Fly63 · neutralproduct/pr

Aug 26

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

GlobeNewswire63 · neutralproduct/pr

Aug 26

Vaxart, Inc. (VXRT) files 8-K

SEC 8-K50 · neutralgeneral

Aug 25

Vaxart Earnings Call Balances Safety Wins and Cash Risk

TipRanks56 · neutralearnings

Aug 22

V2X shares gain after securing Marine Corps contract worth up to $500 million

InvestorsHub67 · bullishproduct/pr

Aug 10

Vaxart Q2 Earnings Call Highlights

Yahoo Finance63 · neutralearnings

Aug 9

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding

Seeking Alpha63 · neutralproduct/pr

Aug 8

Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 8

Vaxart GAAP EPS of -$0.06 beats by $0.06, revenue of $27.19M beats by $0.98M

Seeking Alpha63 · neutralearnings

Aug 6

Vaxart, Inc. (VXRT) files 8-K

SEC 8-K50 · neutralgeneral

Aug 6

Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results

StockTitan55 · neutralearnings

Aug 6

Vaxart Q2 2026 Earnings Preview

Seeking Alpha50 · neutralearnings

Aug 5

Stifel raises V2X stock price target on strong earnings beat

Investing.com Analyst Ratings61 · neutralanalyst

Aug 4

Baird downgrades V2X stock rating to neutral on valuation

Investing.com Analyst Ratings48 · neutralanalyst

Aug 4

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

StockTitan50 · neutralgeneral

Jul 30

Vaxart Revamps Board Committees and Governance Structure

TipRanks50 · neutralgeneral

Jul 28

Vaxart, Inc. (VXRT) files 8-K

SEC 8-K50 · neutralgeneral

Jul 28

Citizens raises V2X stock price target to $102 on MRO strength

Investing.com Analyst Ratings61 · neutralanalyst

Jul 28

Vaxart to Participate in BTIG Biotechnology Conference 2026

StockTitan56 · neutralproduct/pr

Jul 21

Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now

Yahoo Finance48 · neutralgeneral

Jul 20

Open VXRT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →